Dissolved and financials
CVR: 38203312
DKK -5,465
Gross profit
Net result: DKK -5,882
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 18 December 2019
CVR · view overview
3 employees
CVR · 2017
Director role ended: Adam Jun Bohr
CVR · 18/12/2019
View the full event history
Microembed Pharmaceuticals IVS was a Danish company of the type Iværksætterselskab based in Frederiksberg, founded in 2016. The company has been dissolved on 18 December 2019. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 3 employees (2017). In 2018, the company reported a gross profit of DKK -5,465 and a net result of DKK -5,882. Equity in the 2018 report amounted to DKK 12,511.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/01/2018 – 31/12/2018 | -5K | -6K | 26K | 13K | 0 |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. Microembed Pharmaceuticals IVS is registered in the Danish CVR register with the status Dissolved and ceased on 18 December 2019.
The CVR number of Microembed Pharmaceuticals IVS is 38203312.
In 2018, Microembed Pharmaceuticals IVS reported a gross profit of DKK -5,465.
Microembed Pharmaceuticals IVS had 3 employees in 2017 according to the Danish CVR register.
Microembed Pharmaceuticals IVS was founded on 18 November 2016.
Microembed Pharmaceuticals IVS was registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
As of December 18, 2019, Adam Jun Bohr has stepped down as director of Microembed Pharmaceuticals IVS.
Microembed Pharmaceuticals IVS was dissolved on December 18, 2019.
Microembed Pharmaceuticals IVS has published its annual report for 2018. Gross profit came to DKK -5,465, and the net result was DKK -5,882.
Microembed Pharmaceuticals IVS has published its interim report for the period November 18, 2016 to December 31, 2017.
As of November 18, 2016, Adam Jun Bohr is registered as director of Microembed Pharmaceuticals IVS.
Microembed Pharmaceuticals IVS was founded on November 18, 2016.
Companies in the same industry and area
CVR 33498063
CVR 34574995
CVR 56759913
CVR 44952068
CVR 34708215
